Compound Detail
CHEMBL371095
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL371095 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | YUYWSKXPXLUJNA-UHFFFAOYSA-N |
5
Targets
7
Activities
1
Assay Types
0
PK Parameters
11
Publications
0
Known Names
Molecular Properties
466.6
MW (Da)
4.78
ALogP
8
HBA
2
HBD
95.3
PSA (Ų)
0.38
QED
0
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 7 meas. best 6.42
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Mitogen-activated protein kinase kinase kinase 8 CHEMBL4899 | IC50 | 6.42 | 6.42 | 380.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 6.42 | 6.42 | 380.0 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 1 CHEMBL3587 | IC50 | 6.1 | 6.1 | 800.0 | 1 |
| MAP kinase p38 CHEMBL2094115 | IC50 | 5.85 | 5.34 | 1400.0 | 2 |
| Proto-oncogene tyrosine-protein kinase Src CHEMBL267 | IC50 | 4.05 | 4.05 | 90000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Mitogen-activated protein kinase kinase kinase 8 | IC50 | = | 380.0 | nM | 6.42 | Inhibitory activity against human Tpl2 kinase via quantification of MEK phosphor... | 16165349 |
| Unchecked | IC50 | = | 380.0 | nM | 6.42 | Inhibition of Tpl2 kinase assessed as MEK phosphorylation by ELISA | 17664070 |
| Dual specificity mitogen-activated protein kinase kinase 1 | IC50 | = | 800.0 | nM | 6.1 | Inhibitory activity against MEK | 16165349 |
| MAP kinase p38 | IC50 | = | 1400.0 | nM | 5.85 | Inhibition of LPS-induced TNFalpha production in primary human monocytes | 16165349 |
| MAP kinase p38 | IC50 | = | 14900.0 | nM | 4.83 | Inhibition of LPS-induced TNFalpha production in human whole blood | 16165349 |
| Proto-oncogene tyrosine-protein kinase Src | IC50 | = | 90000.0 | nM | 4.05 | Inhibitory activity against Src | 16165349 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 16165349 | 10.1016/j.bmcl.2005.08.029 | MAP kinase p38 | 3 |
| 16165349 | 10.1016/j.bmcl.2005.08.029 | Mitogen-activated protein kinase kinase kinase 8 | 1 |
| 16165349 | 10.1016/j.bmcl.2005.08.029 | Dual specificity mitogen-activated protein kinase kinase 1 | 1 |
| 16165349 | 10.1016/j.bmcl.2005.08.029 | Proto-oncogene tyrosine-protein kinase Src | 1 |
| 16165349 | 10.1016/j.bmcl.2005.08.029 | MAP kinase-activated protein kinase 2 | 1 |
| 16165349 | 10.1016/j.bmcl.2005.08.029 | Protein kinase C (PKC) | 1 |
| 16165349 | 10.1016/j.bmcl.2005.08.029 | Epidermal growth factor receptor | 1 |
| 16165349 | 10.1016/j.bmcl.2005.08.029 | No relevant target | 1 |
| 16165349 | 10.1016/j.bmcl.2005.08.029 | ADMET | 1 |
| 16165349 | 10.1016/j.bmcl.2005.08.029 | Molecular identity unknown | 1 |
| 17664070 | 10.1016/j.bmc.2007.06.054 | Unchecked | 1 |
Data from ChEMBL 36 via Core Engine